Systematic review of real-world studies evaluating the impact of medication non-adherence to endocrine therapies on hard clinical endpoints in patients with non-metastatic breast cancer – András Inotai, Tamás Ágh, Ramona Maris, Dalma Erdősi, Sandor Kovacs, Zoltán Kaló, Elzbieta Senkus, Cancer Treatment Reviews 100(10159):102264, July 2021, DOI: 10.1016/j.ctrv.2021.102264

Quo Vadis HTA for Medical Devices in Central and Eastern Europe? Recommendations to Address Methodological Challenges – Rita Daubner-Bendes, Sándor Kovács, Maciej Niewada, Mirjana Huic, Michael Drummond, Oriana Ciani, Carl Rudolf Blankart, Olena Mandrik, Aleksandra Torbica, John Yfantopoulos, Guenka Petrova, Malwina Holownia-Voloskova, Rod S. Taylor, Maiwenn Al, Oresta Piniazhko, László Lorenzovici, Rosanna Tarricone, Antal Zemplényi, Zoltán Kaló, Frontiers in Public Health, January 2021, DOI 10.3389/fpubh.2020.612410

Cost Assessment of Inpatient Care Episodes of Stroke in Romania – László Lorenzovici, Andrea Székely, Marcell Csanadi, Péter Gaál, Frontiers in Public Health, December 2020, DOI 10.3389/fpubh.2020.605919

Patient-reported symptom burden of chronic graft versus host disease: a systematic literature review – Marcell Csanádi, Tamás Ágh, Szabolcs Farkas-Ráduly, Blanca Gros, Christoph Tapprich, Jeremiah J Trudeau, Jeffrey H Lipton, Jonas Mattsson, Expert Review of Hematology, August 2020, DOI: 10.1080/17474086.2020.1818065

Identifying Patient Access Barriers for Tumor Necrosis Factor Alpha Inhibitor Treatments in Rheumatoid Arthritis in Five Central Eastern European Countries – András Inotai, Dominik Tomek, Maciej Niewada, László Lorenzovici, Martin Kolek, Jakub Weber, Anne-Katrin Kurrat, Emese Virág Kiss, Zoltán Kaló. Frontiers in Pharmacology, June 2020, 11:845, DOI: 10.3389/fphar.2020.00845

Early phase economic evaluation of new generation sequence diagnostics in Multiple Myeloma – Zoltán KALÓ, István VÁLYI-NAGY, Andrea SZÉKELY, Bence SZIKORA, Rita BENDES, Gábor VARGA, László SZILBERHORN,Balázs NAGY, Gábor MIKALA, Imre KACSKOVICS. Value in Health, May 2020, 23:S326-S327, DOI: 10.1016/j.jval.2020.04.1222

Budget Impact of Intravenous Iron Therapy with Ferric Carboxymaltose in Patients with Chronic Heart Failure and Iron Deficiency in Romania – László Lorenzovici, Andrea Székely, Szabolcs Farkas-Ráduly, Ciprian Jitaru, Marcell Csanádi, Journal of Cardiovascular Emergencies 2019;5(4):131-139, DOI: 10.2478/jce-2019-0018

The implications of external price referencing on pharmaceutical list prices in EuropeMarcell Csanádi, Zoltán Kaló, Christian P.J.Prins, dEszter Grélinger, Anna Menczelné Kiss, Frank Ulrich Fricke, Leoš Fuksa, Tomas Tesar, Manoela Manova, László Lorenzovici, Zoltán Vokó, Louis P.Garrison, Article in Health Policy and Technology, Volume 7, Issue 3, September 2018, Pages 243-250, DOI: 10.1016/j.hlpt.2018.07.005

Patient Access, Unmet Medical Need, Expected Benefits, and Concerns Related to the Utilisation of Biosimilars in Eastern European Countries: A Survey of ExpertsAndras Inotai, Marcell Csanadi, Guenka Petrova, Maria Dimitrova, Tomasz Bochenek, Tomas Tesar, Kristina York, Leos Fuksa, Alexander Kostyuk, Laszlo Lorenzovici, Vitaly Omelyanovskiy, Katalin Egyed et al., Academic Editor: Joao Eurico Fonseca, Volume 2018, Article ID 9597362, 9 pages, DOI: 10.1155/2018/9597362

Policy Practices to Maximise Social Benefit from BiosimilarsInotai A., Csanádi M., Vitezic D, Francetic I., Tesar T., Bochenek T., Lorenzovici L.,Dylst P. and Kaló Z., Article in Journal of Bioequivalence & Bioavailability, July 2017, DOI: 10.4172/jbb.1000346

Controlling in Romanian Hospitals: revenues, costs and contribution after salary increase – László Lorenzovici, Andrea Székely, Bernadett Nyulas, Lucia Daina, Aliz Bradács, Article in IME-Interdiszciplináris Magyar Egészségügy 2020;19(1):16-22

Economic Evaluation of Ulipristal Acetate for the Treatment of Patients With Moderate and Severe Symptoms of Uterine Fibroids in RomaniaL. Lorenzovici, A. Székely, T. Ágh, I. Vámossy, L.J. Kelemen, H. Finta, Z. Kaló, VALUE IN HEALTH 17 (2014) A323–A686, DOI: